share_log

Altimmune | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TIAA-CREF Investment Management, LLC(2.88%),Teachers Advisors, LLC(0.32%), etc.

SEC announcement ·  Feb 15 01:07
Summary by Futu AI
On December 31, 2023, Altimmune, Inc., a biopharmaceutical company, was the subject of a Schedule 13G filing with the Securities and Exchange Commission (SEC), indicating changes in ownership by significant investors. The filing, dated February 14, 2024, reports that Nuveen Asset Management, LLC (NAM), TIAA-CREF Investment Management, LLC (TCIM), and Teachers Advisors, LLC (TAL), all based in Delaware, have updated their holdings in Altimmune's common stock. NAM reported ownership of 6,679 shares, TCIM reported 1,549,364 shares, and TAL reported 171,273 shares. Collectively, these holdings represent a total of 3.21% of the company's common stock. The filing specifies that these shares were acquired in the ordinary course of business and not with the intention of changing or influencing the control of Altimmune. The filing was made in accordance with Rule 13d-1(b) of the Securities Exchange Act of 1934, which applies to certain institutional investment managers.
On December 31, 2023, Altimmune, Inc., a biopharmaceutical company, was the subject of a Schedule 13G filing with the Securities and Exchange Commission (SEC), indicating changes in ownership by significant investors. The filing, dated February 14, 2024, reports that Nuveen Asset Management, LLC (NAM), TIAA-CREF Investment Management, LLC (TCIM), and Teachers Advisors, LLC (TAL), all based in Delaware, have updated their holdings in Altimmune's common stock. NAM reported ownership of 6,679 shares, TCIM reported 1,549,364 shares, and TAL reported 171,273 shares. Collectively, these holdings represent a total of 3.21% of the company's common stock. The filing specifies that these shares were acquired in the ordinary course of business and not with the intention of changing or influencing the control of Altimmune. The filing was made in accordance with Rule 13d-1(b) of the Securities Exchange Act of 1934, which applies to certain institutional investment managers.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.